Luye Pharma prices high amid HK IPO flurry

Move follows successful IPOs by Tian Ge Interactive, Beijing Digital Telecom and Beijing Urban Construction. What links these deals? Cornerstone backing.

Luye Pharma prices high amid HK IPO flurry

China’s Luye Pharma Group is set to raise $764 million after pricing an initial public offering of shares in Hong Kong at the top end of its targeted range thanks to heavy investor demand and cornerstone support.

The institutional tranche experienced “double-digit oversubscription,” a banker close to the deal said, describing the book as a mix of long-only institutional investors, sovereign wealth funds and hedge funds. More than 290 institutions participated, the majority located in...

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition


  • 2nd Compliance Summit Southeast Asia

    17 August 2017  |  Singapore
    The 2017 Compliance Summit Southeast Asia will take an in-depth look at the key compliance considerations today with a focus on regulation and new ...